Concepedia

Author

E. Van Cutsem

KU Leuven

Also Known As

E Van Cutsem, E. VAN CUTSEM, E. Van Cutsem, E. van Cutsem, Eric Van Cutsem, Erik Van Cutsem, Erik van Cutsem, V. van den Maegdenbergh

137

Publications

3.3K

Citations

25

H-Index

74

Concepts

All Affiliations

KU LeuvenUniversitair Ziekenhuis LeuvenMemorial Sloan Kettering Cancer CenterJohns Hopkins UniversityUniversity of Michigan
EV

About

E. Van Cutsem is an author at KU Leuven specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

27

749

2

Health Sciences

9

9

295

3

Public Health

2

2

31

4

Engineering

1

1

44

5

Applied Physiology

1

1

44

E. Van Cutsem

×

38

Publications

2.2K

Citations

22

H-Index

YearCitations

Pancreatic adenocarcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Thomas Seufferlein, Jean‐Baptiste Bachet, E. Van Cutsem,

Annals of Oncology

2012

385

ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms

Gianfranco Delle Fave, Dik J. Kwekkeboom, E. Van Cutsem,

Neuroendocrinology

2012

321

Histopathologic Validation of Lymph Node Staging With FDG-PET Scan in Cancer of the Esophagus and Gastroesophageal Junction

Patrick Flamen, Nadine Ectors, E. Van Cutsem,

Annals of Surgery

2000

267

Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis

Linde De Smedt, Julie Lemahieu, Sofie Palmans,

British Journal of Cancer

2015

164

Poorly Differentiated Carcinomas of the Foregut (Gastric, Duodenal and Pancreatic)

Ola Nilsson, E. Van Cutsem, Gianfranco Delle Fave,

Neuroendocrinology

2006

109

51A Docetaxel (D), cisplatin (C) 5-fluorouracil (F) compared to cisplatin (C) and 5-fluorouracil (F) for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma (MGC): Interim results of a randomized phase III trial (V325)

E. Van Cutsem, Vladimir Moiseyenko, S. Tjulandin,

European Journal of Cancer Supplements

2003

90

The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007

E. Van Cutsem, M. Dicato, Karin Haustermans,

Annals of Oncology

2008

70

An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202

Arndt Vogel, Vaibhav Sahai, Antoine Hollebecque,

ESMO Open

2024

54

Final results of CONFIRM 2: A multinational, randomized, double-blind, phase III study in 2nd line patients (pts) with metastatic colorectal cancer (mCRC) receiving FOLFOX4 and PTK787/ZK 222584 (PTK/ZK) or placebo

C.-H. Köhne, E. Bajetta, E. Lin,

Journal of Clinical Oncology

2007

47

Observation of the propagation direction of human electrogastric activity from cutaneous recordings

J. Chen, Joos Vandewalle, Willy Sansen,

Medical & Biological Engineering & Computing

1989

44

Page 1